Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Table 5 Summary of all study serious adverse events

		Arm A (n^a = 3)				Arm B (n^a = 2)				Arm C (n^a = 3)
		Grade				Grade				Grade
Category	Event Term	2	3	4	5	2	3	4	5	2	3	4	5
Blood and lymphatic system disorders	Febrile neutropenia										1
Infections and infestations	Pseudomonas infection										1
	Urinary tract infection						1
Metabolism	Hypokalaemia							1
	Hypophosphataemia						1
Nervous system disorders	Encephalopathy										1

ISSN: 1471-2407